Table 2.
Cognitive cues involved in clinicians’ detection of potentially harmful drug–drug interactions (DDIs), as listed in figure 1 step 1.
| Cognitive cue # | Definition | Quote |
| 1. Alert in EHR | Clinician learns about a potential DDI via a computerised DDI alert in the EHR. | “An alert popped for the linezolid:bupropion interaction.”—physician A |
| 2. Detected on own | Clinician recognises the DDI concern based on their own knowledge about interacting medications, independent of any alert. | “So anytime I see amiodarone or warfarin on the same patient…[I see if] the interaction has already been accounted for….so I do that routinely on any patient that’s on both of those medications.”—pharmacist A |
| 3. Notified by another individual | The clinician becomes aware of a potential DDI because a DDI concern is raised by another individual, such as the patient, caregiver or another clinician. | “…they dispensed the medication, and then the [patient’s] son called back concerned about the drug interaction.”—pharmacist B |
Cues were derived from inductive qualitative analysis of clinicians’ reported incidents. The table above presents a definition for each cue, along with an example of a quote.
DDI, drug–drug interaction; EHR, electronic health record.